Legend Biotech Corporation (NASDAQ:LEGN) Q2 2023 Earnings Call Transcript August 15, 2023
Legend Biotech Corporation misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $0.69.
Operator: Good morning and thank you for standing by. Welcome to the Legend Biotech Reports Second Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]...
